Blogs about BIIB - Stockpickr! Your Source for Stock Ideas

Blogs about BIIB

Blogs	Description	Date Updated
What does Carl Icahn know about Biogen anyway?	Filed under: ManagementShares of Biogen Idec Inc. (NASDAQ: BIIB) plummeted on news that its multiple-sclerosis drug Tysabri was linked to brain infections causing death, leaving 4.3% shareholder Carl Icahn with a hefty paper loss. But Icahn didn't back down. Having already pushed for one unsuccessful effort to sell the company, and having lost a bid for three seats on the board of directors, Icahn filed a 13-D announcing that he had raised his stake to 6.1%, buying in the wake of the brain infe...	August 13, 2008
Icahn Boosts Stake in Biogen Idec (BIIB) to 6% Following TYSABRI Sell-Off	In a 13D filing on Biogen Idec (Nasdaq: BIIB), Carl Icahn disclosed he raised his stake in the company to 6.03% (17,511,304 shares). This is up from the 9,948,723 share stake held at the quarter ended 3/31/08.Icahn noted that his representatives have had, and from time to time may seek to continue to have, discussions with representatives of Biogen Idec to discuss general business issues relating to the Issuer as well as their concerns relating to shareholder value.Icahn disclosed he paid $916,5...	August 12, 2008
Top Pre-Market Analyst Downgrades (BIIB, CBEY, EHTH, NT, OSK, PAET, RYAAY, SVNT)	These are some of the key analyst downgrades and negative analyst calls we have seen early this Monday morning with over 2 hours to open: Biogen Idec (BIIB)... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	August 04, 2008
Jim Cramer’s Stop Trading!	Jim Cramer told viewers of CNBC’s “Stop Trading!” segment Friday to buy Starbucks (SBUX). Cramer thinks that Starbucks will be much higher in 15 months. Switching gears to financial stocks, Cramer said things are better at Wachovia (WB). For healthcare stocks, Cramer said he can’t find a stock with an intriguing pipeline and he can’t come up with a reason to buy Biogen (BIIB). He also disclosed he sold some of his Schering-Plough (SGP) position for his charitable tr...	August 02, 2008
Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)	This morning's share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We do not want to try to sound as though... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	August 01, 2008
Option Update: Biogen and Elan trading lower on Tysabri link to brain infection	Filed under: Major movement, OptionsBiogen (NASDAQ: BIIB) was trading at $54.71 in pre-open trading, below its close of $69.76 Thursda. BIIB and Elan (NYSE: ELN) announced their multiple sclerosis treatment Tysabri, was linked to brain infection. BIIB August option implied volatility was at 42, September at 39; near its 26-week average of 39 according to Track Data, suggesting non-directional price movement. ELN was trading at $10.78 in pre-open trading, below its close of $20.05. ELN August op...	August 01, 2008
Pre-market movers: (GM) (CNXT) (SCOR)	Filed under: Before the bell, General Motors (GM)ComScore (NASDAQ: SCOR) is up 12% on strong earnings. Conexant (NASDAQ: CNXT) is up 11% after reporting a good quarter. GM (NYSE: GM) is off 7% on huge write-offs. Biogen Idec (NASDAQ: BIIB) is off 23% on news that one of its drugs creates severe complications. Stocks may trade differently in the pre-market than they do in the regular session. Douglas A. McIntyre is an editor at 247wallst.com. Permalink \| Email this \| Comments ...	August 01, 2008
Fast Money Recap	Word On The Street WORD VIDEO HERE August Prediction The traders gave out their predictions for August. Jon Najarian said he thinks the financials have bottomed and he likes Prudential (PRU) and American International Group (AIG). He pointed out that AIG has unusual options activity. Adami said avoid AIG because the company is too exposed to the financial services market. Macke said rent stocks in August don’t buy them. Yahoo Chat The traders spoke with Thomas Weisel Partners analyst Chris...	July 31, 2008
ETF Pick of the Week: PJP	Here's my ETF Pick of the Week: PowerShares Dynamic Pharma (PJP). PJP is a basket of companies selected by a model based on a variety of investment criteria including growth, stock valuation, timeliness and risk factors. This ETF contains about 30 companies fairly evenly weighted. 57% are large cap, 24% midcap with the balance small cap companies. The top holding in PJP is Genentech and it also holds other established biotech companies such as Amgen (AMGN), Gilead (GILD), and Biogen (BIIB). P...	July 30, 2008
Fast Money Recap	Word On The Street WORD VIDEO HERE Dennis Gartman The traders spoke with Dennis Gartman, author of The Gartman Letter, about the future of oil prices. Gartman said the longs are throwing up and the shorts are feeling like kings. He doesn’t think that trend is about to change for crude oil. He said gold looks awful and didn’t trade up when it should have. Gartman thinks gold and the dollar are changing their major trends. He disclosed he is short crude oil here and would look to buy t...	July 29, 2008

Enter search text here: